↓ Skip to main content

Prognostic Value of Radiomic Features of 18F-FDG PET/CT in Patients With B-Cell Lymphoma Treated With CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T Cells

Overview of attention for article published in Frontiers in oncology, February 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prognostic Value of Radiomic Features of 18F-FDG PET/CT in Patients With B-Cell Lymphoma Treated With CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T Cells
Published in
Frontiers in oncology, February 2022
DOI 10.3389/fonc.2022.834288
Pubmed ID
Authors

Yeye Zhou, Jihui Li, Xiaoyi Zhang, Tongtong Jia, Bin Zhang, Na Dai, Shibiao Sang, Shengming Deng

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 36%
Student > Bachelor 1 7%
Other 1 7%
Student > Master 1 7%
Student > Ph. D. Student 1 7%
Other 0 0%
Unknown 5 36%
Readers by discipline Count As %
Medicine and Dentistry 5 36%
Pharmacology, Toxicology and Pharmaceutical Science 2 14%
Chemistry 1 7%
Unknown 6 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 February 2022.
All research outputs
#15,811,637
of 25,478,886 outputs
Outputs from Frontiers in oncology
#5,005
of 22,568 outputs
Outputs of similar age
#259,814
of 520,187 outputs
Outputs of similar age from Frontiers in oncology
#303
of 1,455 outputs
Altmetric has tracked 25,478,886 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,568 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 520,187 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,455 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.